AUM Biosciences closes US $ 27 million `Series A’ funding round
Everlife leads the series A round, and SPRIM Global Investments participates in the financing syndicate
Everlife leads the series A round, and SPRIM Global Investments participates in the financing syndicate
In Q2FY22, growth from Covid-driven products in the domestic branded formulation sales should dissipate on a QoQ basis as new covid cases have declined sharply. Vishal Manchanda, research analyst Nirmal Bang gives a preview of pharma companies in this report
The rates for over 400 procedures were revised
According to IQVIA, US sales of Everolimus (Afinitor) tablets were approximately US $ 675 million in the 12 months ending July 2021
The company plans to submit the IND application by the end of 2021
This one-of-a-kind innovation challenge is aimed at addressing the challenges faced by healthcare providers in digital technology adoption
India’s first gender-neutral HPV vaccine to help reduce HPV -related disease burden in Indian girls, women and boys
This project will be conducted at the “NURA,” a health screening centre that Fujifilm opened in India in February this year
CuraTeQ Biologics is on track for filing a second oncology biosimilar
These aprons utilise phase change materials that absorb, store and release heat for optimal thermal comfort
Subscribe To Our Newsletter & Stay Updated